Tag: schizophrenia
MicroRNAs as Biomarkers for Psychiatric Conditions: A Review of Current Research
by Anoop Narahari, MD; Mariyah Hussain, MD; and Venkatesh Sreeram, MD Drs. Narahari, Hussain, and Sreeram are from the University of Alabama, Department of Psychiatry and Behavioral sciences, Birmingham, Alabama. Innov Clin Neurosci. 2017;14(1–2):53–55
Severe Hypoglycemia Associated With Tiapride In An Elderly Patient With diabetes and Psychosis
Innov Clin Neuro. 2017;14(1–2):12–13
Cariprazine for Schizophrenia and Bipolar Disorder
by Jonathan R. Scarff, MD Dr. Scarff is a staff psychiatrist at the Veterans Affairs Outpatient Clinic in Spartanburg, South Carolina, USA Innov Clin Neurosci. 2016;13(9–10):49–52 Funding: The author has received no financial support for the writing of this manuscript. Financial Disclosures: The authors has no financial dislosures relevant to the content of this article. […]
The Neuroscience Report—Vol. 45 (September 15, 2016): Schizophrenia
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This week’s […]
Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases
by Joanna P. MacEwan, PhD; Seth Seabury, PhD; Myrlene Sanon Aigbogun, MPH; Siddhesh Kamat, MS, MBA; Emma van Eijndhoven, MS, MA; Clement Francois, PhD; Crystal Henderson, PharmD, BCPP; and Leslie Citrome, MD, MPH Dr. MacEwan and Ms. van Eijndhoven are with Precision Health Economics in Los Angeles, California, USA; Dr. Seabury is with the University […]
Brexpiprazole: A New Treatment Option for Schizophrenia
by Jonathan R. Scarff, MD Dr. Scarff is with Veterans Affairs Outpatient Clinic, Spartanburg, South Carolina. Innov Clin Neurosci. 2016;13(7–8):26–29 Funding: No funding was received for the preparation of this manuscript. Financial disclosures: The author has no financial disclosures relevant to the content of this article. Key words: Schizophrenia, brexpiprazole, antipsychotic Abstract: Schizophrenia occurs in […]
Physician Prescribing Practices of Vitamin D in a Psychiatric Hospital
by Kimberly B. Mulcahy, PharmD; Eileen Trigoboff, RN, DNS; Lewis Opler, MD, PhD; and Tammie Lee Demler, BS, PharmD, MBA Drs. Trigoboff, Demler, and Mulcahy are with Buffalo Psychiatric Center, New York State Office of Mental Health, and State University of New York, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York; […]
Letter to the editor: Decrease in Reciprocal Fairness Feeling of patients with Polydipsic Schizophrenia
Dear Editor: Polydipsia can lead to episodic life-threatening water intoxication and is a serious problem in many patients with chronic schizophrenia.[1] Although multiple factors have been implicated,[2] the reason why polydipsic-related overhydration behavior is repeated in some patients with schizophrenia remains unclear. Game theoretical modeling may offer a new tool for investigating behavioral impairments in […]
Efficacy of Transcranial Magnetic Stimulation (TMS) in the Treatment of Schizophrenia: A Review of the Literature to Date
by Jonathan C. Cole, DO; Carolyn Green Bernacki, DO; Amanda Helmer, RN; Narsimha Pinninti, MD; and John P. O’Reardon, MD All from the Rowan School of Osteopathic Medicine, Stratford, New Jersey Innov Clin Neurosci. 2015;12(7–8):12–19 Funding: No funding was received for the preparation of this manuscript. Financial disclosures: The authors have no conflicts of interest relevant […]
The Neuroscience Report—Vol. 15 (August 10, 2015): Antipsychotic Medications
Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. Volume 15 (August 10, 2015): Antipsychotic Medications Journal Articles Rationale for Iloperidone […]
